Crisis of COPD in China: the future is now

Affiliations

¹ Centre for Heart Lung Innovation, St Paul's Hospital and Division of Respiratory Medicine, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada; The Respiratory Department of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Centre for Heart Lung Innovation, St Paul's Hospital and Division of Respiratory Medicine, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada. Electronic address: don.sin@hli.ubc.ca.

Comment

Yilan Sun et al. Lancet Respir Med. 2018 Jun.

. 2018 Jun;6(6):404-405.

doi: 10.1016/S2213-2600(18)30133-4. Epub 2018 Apr 9.

¹ Centre for Heart Lung Innovation, St Paul's Hospital and Division of Respiratory Medicine, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada; The Respiratory Department of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Centre for Heart Lung Innovation, St Paul's Hospital and Division of Respiratory Medicine, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada. Electronic address: don.sin@hli.ubc.ca.

No abstract available

Comment on

Chronic obstructive pulmonary disease in China: a nationwide prevalence study.
Fang L, Gao P, Bao H, Tang X, Wang B, Feng Y, Cong S, Juan J, Fan J, Lu K, Wang N, Hu Y, Wang L. Fang L, et al. Lancet Respir Med. 2018 Jun;6(6):421-430. doi: 10.1016/S2213-2600(18)30103-6. Epub 2018 Apr 9. Lancet Respir Med. 2018. PMID: 29650407 Free PMC article.